Overall survival was shorter in patients exhibiting high expression of IL6 than in those showing low expression in the lung adenocarcinoma group (P < 0.001, log-rank test), but not in the lung squamous cell carcinoma group (P = 0.3175, log-rank test) (Additional file 1: Figure S1D). The gene discussed is IL6; the disease is lung adenocarcinoma.